Advertisement

JMEE - ETF AI Analysis

Compare

Top Page

JMEE

JPMorgan Market Expansion Enhanced Equity ETF (JMEE)

Rating:67Neutral
Price Target:
$70.00
The JPMorgan Market Expansion Enhanced Equity ETF (JMEE) has a solid overall rating, reflecting a mix of strong performers and some weaker holdings. Comfort Systems USA (FIX) and United Therapeutics (UTHR) stand out as key contributors due to their robust financial performance, strategic growth initiatives, and bullish technical momentum. However, holdings like SanDisk (SNDK) and Lumentum Holdings (LITE) have faced financial challenges and valuation concerns, which may have slightly weighed down the fund’s rating. A potential risk factor is the ETF's exposure to stocks with high valuation concerns, which could limit upside potential.
Positive Factors
Strong Top Holdings
Several top holdings, such as SanDisk Corp and Comfort Systems, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Industrials, Financials, and Technology, reducing reliance on any single industry.
Low Expense Ratio
With a competitive expense ratio of 0.24%, this ETF offers cost-efficient exposure compared to many actively managed funds.
Negative Factors
High U.S. Concentration
The ETF has over 96% exposure to U.S. companies, limiting diversification across global markets.
Mixed Recent Performance
While the ETF has shown positive three-month and year-to-date performance, its one-month returns have been slightly negative, indicating short-term volatility.
Underperforming Holdings
Some holdings, like Exelixis, have lagged in year-to-date performance, which could drag on overall fund returns.

JMEE vs. SPDR S&P 500 ETF (SPY)

JMEE Summary

The JPMorgan Market Expansion Enhanced Equity ETF (JMEE) is a fund designed to give investors access to mid-sized and smaller companies that have strong growth potential. Unlike funds focused on large, established companies, JMEE targets businesses that are poised for expansion, offering a chance to diversify your investments. Some of the companies it includes are United Therapeutics and Pure Storage, which are leaders in their respective industries. This ETF could be a good choice for someone looking to diversify their portfolio and tap into the growth potential of smaller companies. However, new investors should know that mid-cap and small-cap stocks can be more volatile, meaning their prices may rise and fall more dramatically than larger companies.
How much will it cost me?The expense ratio for the JPMorgan Market Expansion Enhanced Equity ETF (JMEE) is 0.24%, which means you’ll pay $2.40 per year for every $1,000 invested. This is lower than average for actively managed ETFs, as it uses JPMorgan's strategies to enhance returns while keeping costs relatively low.
What would affect this ETF?JMEE's focus on U.S. mid-cap and small-cap companies could benefit from economic growth and innovation in sectors like technology and industrials, which are key areas of exposure for the ETF. However, it may face challenges during periods of economic uncertainty or rising interest rates, which can negatively impact smaller companies and sectors like real estate and consumer cyclical. Regulatory changes or shifts in market sentiment could also influence the performance of its top holdings.

JMEE Top 10 Holdings

JMEE is leaning heavily into mid-cap and small-cap stocks, with a notable focus on industrials, financials, and technology sectors. Comfort Systems and Pure Storage are rising stars, driving performance with strong growth and bullish momentum, though valuation concerns linger. Fabrinet is also contributing positively, despite hints of bearish technical signals. On the flip side, Exelixis is lagging, weighed down by weak technical indicators despite its promising oncology advancements. With its U.S.-centric portfolio, JMEE offers a dynamic mix of growth opportunities, though sector concentration in cyclical industries adds a layer of risk.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
2.68%$54.48M
SanDisk Corp0.94%$19.15M$37.25B
59
Neutral
Comfort Systems0.83%$16.90M$32.08B103.95%
80
Outperform
United Therapeutics0.83%$16.88M$20.08B31.38%
79
Outperform
Coherent Corp0.82%$16.74M$21.90B45.85%
67
Neutral
nVent Electric0.62%$12.50M$17.19B41.83%
79
Outperform
Lumentum Holdings0.61%$12.46M$16.46B193.49%
61
Neutral
Fabrinet0.61%$12.33M$14.81B79.38%
75
Outperform
Pure Storage0.57%$11.67M$27.80B69.93%
72
Outperform
Twilio0.57%$11.50M$19.01B24.70%
70
Neutral

JMEE Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
63.39
Negative
100DMA
62.29
Negative
200DMA
59.63
Positive
Market Momentum
MACD
-0.26
Positive
RSI
39.61
Neutral
STOCH
18.25
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JMEE, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 63.34, equal to the 50-day MA of 63.39, and equal to the 200-day MA of 59.63, indicating a neutral trend. The MACD of -0.26 indicates Positive momentum. The RSI at 39.61 is Neutral, neither overbought nor oversold. The STOCH value of 18.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JMEE.

JMEE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.99B0.24%
67
Neutral
$9.99B0.21%
73
Outperform
$9.99B0.15%
74
Outperform
$9.93B0.12%
74
Outperform
$1.12B0.60%
72
Outperform
$1.05B0.55%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JMEE
JPMorgan Market Expansion Enhanced Equity ETF
61.74
-1.02
-1.63%
DUHP
Dimensional US High Profitability ETF
AVUS
Avantis U.S. Equity ETF
DFAU
Dimensional US Core Equity Market ETF
SMIG
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
TMSL
T. Rowe Price Small-Mid Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement